KRYSTAL BIOTECH INC (KRYS:NASDAQ)
$275.94 3.28 (1.203%)
Analysed KRYSTAL BIOTECH INC (KRYS:NASDAQ) News Sources
Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026
21-04-2026
yahoo.com
3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist
16-04-2026
fool.com
Is Vertex Pharmaceuticals' Empire in Trouble?
16-04-2026
fool.com
Could This Under-the-Radar Healthcare Stock Set You Up for Life?
07-04-2026
fool.com
3 Insider-Owned Growth Companies With Up To 81% Earnings Expansion
01-04-2026
yahoo.com
Exploring Three High Growth Tech Stocks In The US Market
31-03-2026
yahoo.com
Assessing Krystal Biotech (KRYS) Valuation After Recent Share Price Weakness
29-03-2026
yahoo.com
MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance
29-03-2026
247wallst.com
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
23-03-2026
yahoo.com
Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Data
20-03-2026
yahoo.com
What is the current price of KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The current price of KRYSTAL BIOTECH INC (KRYS:NASDAQ) is $275.94.
KRYSTAL BIOTECH INC (KRYS:NASDAQ) absolute price change since previous trading day?
The absolute price change of KRYSTAL BIOTECH INC (KRYS:NASDAQ) since the previous trading day is $3.28.
KRYSTAL BIOTECH INC (KRYS:NASDAQ) percentage price change since previous trading day?
The percentage price change of KRYSTAL BIOTECH INC (KRYS:NASDAQ) since the previous trading day is 1.203%.
What is the most recent average sentiment score for KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The most recent average sentiment score for KRYSTAL BIOTECH INC (KRYS:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The most recent sentiment for KRYSTAL BIOTECH INC (KRYS:NASDAQ) is .
SEC-8K** Filing Available For KRYSTAL BIOTECH INC (KRYS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.